Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zoliflodacin versus ceftriaxone plus azithromycin for uncomplicated gonorrhoea
2019-000990-22Phase 3Completed
- Sponsor
- GARDP
- Start
- Dec 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in gonorrhea comparing Zoliflodacin with Ceftriaxone + azithromycin (2 arms). Started Dec 2021; status: completed.
02
Drugs
zoliflodacinceftriaxoneazithromycin
03
Conditions
gonorrhea
Beyond the preview
Go deeper on 2019-000990-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000990-22.